LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Brady Shirley: New President, CEO of DJO Global
People In The News

Brady Shirley: New President, CEO of DJO Global

November 28, 2016 2 min read Premium comments

Advertisement

Brady Shirley: New President, CEO of DJO Global
Brady Shirley

Brady Shirley is the new President and Chief Executive Officer at DJO Global, Inc.! Shirley is taking the place of Mike Mogul, who stepped down from his post as of November 14, 2016. Mogul will stay on until the end of the year to ensure a smooth transition.

“We are delighted to announce the appointment of Brady Shirley as President and Chief Executive Officer. Since Brady joined DJO, the surgical business has more than doubled in revenue and profitability, ” said Mike Zafirovski, DJO’s chairman of the board of directors, in the November 14, 2016 news release. “The Board unanimously agrees that Brady’s leadership experience, coupled with his innovative and strategic thinking and proven track record of delivering results, make him the right person to drive DJO’s dual imperatives of achieving sustainable above market growth and driving cost and service leadership in all of our activities.”

Shirley is very familiar with the company, having most recently served as the president of the DJO Surgical business, a position he was appointed to in March 2014. As noted in the news release, “From 2009 to 2013, Shirley was the CEO and Director of Innovative Medical Device Solutions (‘IMDS’), a company that provides comprehensive product development, manufacturing and supply chain management solutions for medical devices companies within the orthopedic medical device industry. At IMDS, Shirley managed the integration of four companies, consolidated the capital structure and led a successful sale of the business in 2013. From December 1992 to August 2009, Shirley had several key leadership positions with Stryker Corporation, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy. At Stryker, Shirley was responsible for all domestic operations and profit and loss for the Communications division and was responsible for global product development and sales and marketing for the Endoscopy division. Shirley received a Bachelor of Business Administration in Finance from the University of Texas, Austin.

“I am honored and excited to lead DJO through what I would consider to be a unique evolution. Our fast growing surgical business, our market leading bracing and vascular business and rapidly expanding consumer business create a broad base for expansive revenue growth and operational productivity today and tomorrow, ” said Shirley.

“We would like to take this opportunity to thank Mike for his many contributions over the past 5 [five] years. Under his leadership, DJO has grown significantly faster than our competitors, and our new product innovation has increased four-fold. I also want to commend Mike for helping recruit and develop many talented leaders in the company, which will serve us well in the future, ” said Zafirovski.

“I am proud of how our team has created a company that is building a bright future, spanning the episode of orthopedic care, leading in its markets and realizing the vision of Motion is Medicine, ” said Mogul. “I am convinced that Brady and the strong team that he will lead will demonstrate the great impact that DJO can make.”

Brady Shirley told OTW, “We are positioned to grow very well today from two strong platforms in our Bracing and our Surgical Implant business. In prior periods, we were largely positioned in only once space, which is great for focus but challenging for depth. Today, we have the stability of two with opportunities for multiple adjacencies.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy